Diabetes Research and Clinical Practice
Volume 70, Issue 2 , Pages 103-109 , November 2005

Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats

  • Sema Bolkent

      Affiliations

    • Department of Medical Biology, Cerrahpasa Faculty of Medicine, Istanbul University, 34098-Cerrahpasa, Istanbul, Turkey
    • Corresponding Author InformationCorresponding author. Fax: +90 212 632 00 50.
    • ,
  • Sehnaz Bolkent

      Affiliations

    • Department of Biology, Faculty of Science, Istanbul University, 34459-Vezneciler, Istanbul, Turkey
    • ,
  • Refiye Yanardag

      Affiliations

    • Department of Chemistry, Faculty of Engineering, Istanbul University, 34320-Avcilar, Istanbul, Turkey
    • ,
  • Sevim Tunali

      Affiliations

    • Department of Chemistry, Faculty of Engineering, Istanbul University, 34320-Avcilar, Istanbul, Turkey

,Accepted 9 February 2005.

References 

  1. Verma S, Cam MC, McNeill JH. Nutritional factors that can favourably influence the glucose/insulin system: Vanadium. J. Am. College Nutr. 1998;17:11–18
  2. Nechay BR. Mechanisms of action of vanadium. Ann. Rev. Pharm. Toxicol. 1984;24:501–524
  3. Erdmann E, Werdan K, Krawietz W, Schmitz W, Scholz H. Vanadate and its significance in biochemistry and pharmacology. Biochem. Pharm. 1984;33:945–950
  4. Dafnis E, Sabatini S. Biochemistry and pathophysiology of vanadium. Nephron. 1994;67:133–143
  5. Badmaev V, Prakash S, Majeed M. Vanadium: a review of its potential role in the fight against diabetes. J. Altern. Complem. Med. 1999;5:273–291
  6. Rehder D. Biological, medicinal aspects of vanadium. Inorg. Chem. Commun. 2003;6:604–617
  7. Tsiani E, Fantus IG. Vanadium compounds. Biological actions and potential as pharmacological agents. Trends Endocrinol. Metab. 1997;8:51–58
  8. Conconi MT, DeCarlo E, Vigolo S, et al. Effects of some vanadyl coordination compounds on the in vitro insulin release from rat pancreatic islets. Horm. Metab. Res. 2003;35:402–406
  9. Eriksson JW, Lönnroth P, Smith U. Vanadate increases cell surface insulin binding and improves insulin sensitivity in both normal and insulin-resistant rat adipocytes. Diabetologia. 1992;35:510–516
  10. Clark AS, Fagan JM, Mitch WE. Selectivity of the insulin-like actions of vanadate on glucose and protein metabolism in skeletal muscle. Biochem. J. 1985;232:273–276
  11. Cam MC, Brownsey RW, McNeill JH. Mechanisms of vanadium action: insulin-mimetic or insulin-enhancing agent. Can. J. Physiol. Pharm. 2000;78:829–847
  12. Bendayan M, Gingras D. Effects of vanadate administration on blood glucose and insulin levels as well as on the exocrine pancreatic function in streptozotocin-diabetic rats. Diabetologia. 1989;32:561–567
  13. Meyerovitch J, Farfel Z, Sack J, Shechter Y. Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. J. Biol. Chem. 1987;262:6658–6662
  14. Brand RM, Hamel FG. Transdermally delivered peroxovanadium can lower blood glucose levels in diabetic rats. Int. J. Pharm. 1999;183:117–123
  15. Cadene A, Gross R, Poucheret P, et al. Vanadyl sulphate differently influences insulin response to glucose in isolated pancreas of normal rats after in vivo or in vitro exposure. Eur. J. Pharm. 1996;318:145–151
  16. Goldfine AB, Patti ME, Zuberi L, et al. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies. Metabolism. 2000;49:400–410
  17. Sakurai H, Tsuchiya K, Nukatsuka M, Sofue M, Kawada J. Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats. J. Endocrinol. 1990;126:451–459
  18. Shechter Y, Goldwase I, Mironchik M, Fridkin M, Gehel D. Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes. Coord. Chem. Rev. 2003;237:3–11
  19. Venkatesan N, Avidan A, Davidson MB. Antidiabetic action of vanadyl in rats independent of in vivo insulin-receptor kinase activity. Diabetes. 1991;40:492–498
  20. Dehghani GA, Sotoodeh M, Omrani GhR. Trophic effects of vanadium on beta-cells of STZ-induced insulin dependent diabetic rats and evidence for long term relief of diabetes mellitus. Indian J. Med. Res. 1999;110:70–75
  21. Srivastava AK. Anti-diabetic and toxic effects of vanadium compounds. Mol. Cell. Biochem. 2000;206:177–182
  22. Mongold JJ, Cros GH, Vian L, et al. Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic B-cell morphology. Pharm. Toxicol. 1990;67:192–198
  23. Cam MC, Li WM, McNeill JH. Partial preservation of pancreatic β-cells by vanadium: evidence for long-term amelioration of diabetes. Metabolism. 1997;46:769–778
  24. Yao J, Battell ML, McNeill JH. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction. Can. J. Physiol. Pharm. 1997;75:83–90
  25. Jound A, Lambert AE, Stauffacher W, Renold AE. Diabetogenic action of streptozotocin. Relationship of dose to metabolic response. J. Clin. Invest. 1969;48:2129–2139
  26. Relander A, Raiha CE. Differences between the enzymatic and toluidine methods of blood glucose determination. Scand. J. Clin. Lab. Invest. 1963;15:221–224
  27. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 1963;61:882–888
  28. J.L. Hintze, Copyright C, 865, East 400, North Kaysville, UT, 84 (1986) 037 (801), 546-0445.
  29. Smith JB. Vanadium ions stimulate DNA synthesis in Swiss mouse 3T3 and 3T6 cells. Proc. Natl. Acad. Sci. USA. 1983;80:6162–6166
  30. Dai S, Thompson KH, McNeill JH. One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate. Pharm. Toxicol. 1994;74:101–109
  31. Cam MC, Rodrigues B, McNeill JH. Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes. Eur. J. Endocrinol. 1999;141:546–554
  32. Fantus IG, Tsiani E. Multifunctional actions of vanadium compounds on insulin signaling pathways: evidence for preferential enhancement of metabolic versus mitogenic effects. Mol. Cell. Biochem. 1998;182:109–119
  33. Cam MC, Pederson RA, Brownsey RW, McNeill JH. Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats. Diabetologia. 1993;36:218–224
  34. Oster MH, Llobet JM, Domingo JL, German JB, Keen CL. Vanadium treatment of diabetic Sprague-Dawley rats results in tissue vanadium accumulation and pro-oxidant effects. Toxicology. 1993;83:115–130
  35. Sekar N, Kanthasamy A, William S, Balasubramaniyan N, Govindasamy S. Antioxidant effect of vanadate on experimental diabetic rats. Acta Diabetol. Lat. 1990;27:285–293
  36. Yarat A, Tunali T, Yanardag R, et al. The effect of glurenom (gliquidone) on lenses and skin in experimental diabetes. Free Radic. Biol. Med. 2001;31:1038–1042

☆ This study has been presented in part at Joint meeting of the British Association of Clinical Anatomists and the Spanish Anatomical Society, Barcelona, Spain, July 22–23, 2002. Abstracts published European Journal of Anatomy, July 2002, vol. 6, Supplement 1, p. 40.

PII: S0168-8227(05)00036-7

doi: 10.1016/j.diabres.2005.02.003

Diabetes Research and Clinical Practice
Volume 70, Issue 2 , Pages 103-109 , November 2005

Article Tools

* Image Usage & Resolution